Rare case report: a case of histological type transformation of lung cancer caused by neoadjuvant immunotherapy

Lung cancer remains the leading cause of cancer-related mortality, with 1.8 million deaths per year. Small cell lung cancer and non-small cell lung cancer (NSCLC) are the main cancer types. Approximately 85% of cases are NSCLC, including adenocarcinoma, squamous cell carcinoma, and large cell carcin...

Full description

Bibliographic Details
Main Authors: Quanqing Li, Guangxin Zhang, Hao Yang, Jindong Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-02-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1329152/full
_version_ 1797307031347003392
author Quanqing Li
Guangxin Zhang
Hao Yang
Jindong Li
author_facet Quanqing Li
Guangxin Zhang
Hao Yang
Jindong Li
author_sort Quanqing Li
collection DOAJ
description Lung cancer remains the leading cause of cancer-related mortality, with 1.8 million deaths per year. Small cell lung cancer and non-small cell lung cancer (NSCLC) are the main cancer types. Approximately 85% of cases are NSCLC, including adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. In this reported treatment case, the tumor histological type changed after targeted therapy, which has not been previously well documented. The patient was a 67-year-old woman diagnosed with squamous cell carcinoma via bronchoscopy. She received five neoadjuvant immune monotherapies. The lesion shrank but then progressed, with a diagnosis of small cell carcinoma via bronchoscopy. This finding suggests that tumor acquisition of resistance as manifested by cancer-type changes needs consideration and study in the application of this particular type of immunotherapy.
first_indexed 2024-03-08T00:51:27Z
format Article
id doaj.art-e68dd898add04f2f8303d4490300e504
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-03-08T00:51:27Z
publishDate 2024-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-e68dd898add04f2f8303d4490300e5042024-02-15T04:41:10ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2024-02-011410.3389/fonc.2024.13291521329152Rare case report: a case of histological type transformation of lung cancer caused by neoadjuvant immunotherapyQuanqing LiGuangxin ZhangHao YangJindong LiLung cancer remains the leading cause of cancer-related mortality, with 1.8 million deaths per year. Small cell lung cancer and non-small cell lung cancer (NSCLC) are the main cancer types. Approximately 85% of cases are NSCLC, including adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. In this reported treatment case, the tumor histological type changed after targeted therapy, which has not been previously well documented. The patient was a 67-year-old woman diagnosed with squamous cell carcinoma via bronchoscopy. She received five neoadjuvant immune monotherapies. The lesion shrank but then progressed, with a diagnosis of small cell carcinoma via bronchoscopy. This finding suggests that tumor acquisition of resistance as manifested by cancer-type changes needs consideration and study in the application of this particular type of immunotherapy.https://www.frontiersin.org/articles/10.3389/fonc.2024.1329152/fullhistological type transformationneoadjuvant immunotherapysmall cell lung cancerdrug resistancesquamous cell lung carcinoma
spellingShingle Quanqing Li
Guangxin Zhang
Hao Yang
Jindong Li
Rare case report: a case of histological type transformation of lung cancer caused by neoadjuvant immunotherapy
Frontiers in Oncology
histological type transformation
neoadjuvant immunotherapy
small cell lung cancer
drug resistance
squamous cell lung carcinoma
title Rare case report: a case of histological type transformation of lung cancer caused by neoadjuvant immunotherapy
title_full Rare case report: a case of histological type transformation of lung cancer caused by neoadjuvant immunotherapy
title_fullStr Rare case report: a case of histological type transformation of lung cancer caused by neoadjuvant immunotherapy
title_full_unstemmed Rare case report: a case of histological type transformation of lung cancer caused by neoadjuvant immunotherapy
title_short Rare case report: a case of histological type transformation of lung cancer caused by neoadjuvant immunotherapy
title_sort rare case report a case of histological type transformation of lung cancer caused by neoadjuvant immunotherapy
topic histological type transformation
neoadjuvant immunotherapy
small cell lung cancer
drug resistance
squamous cell lung carcinoma
url https://www.frontiersin.org/articles/10.3389/fonc.2024.1329152/full
work_keys_str_mv AT quanqingli rarecasereportacaseofhistologicaltypetransformationoflungcancercausedbyneoadjuvantimmunotherapy
AT guangxinzhang rarecasereportacaseofhistologicaltypetransformationoflungcancercausedbyneoadjuvantimmunotherapy
AT haoyang rarecasereportacaseofhistologicaltypetransformationoflungcancercausedbyneoadjuvantimmunotherapy
AT jindongli rarecasereportacaseofhistologicaltypetransformationoflungcancercausedbyneoadjuvantimmunotherapy